Nexalin Technology, Inc. SEC filings NXL

Nexalin Technology, Inc. has 204 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form ARS, was filed on Jul 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.

Nexalin Technology, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 1, 2026 Sep 30, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Oct 1, 2026 Sep 28, 2026
8-K Current report
Listing notice
Sep 28, 2026 Sep 25, 2026
8-K Current report
Officer or director change
Sep 2, 2026 Aug 28, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 27, 2026 Aug 26, 2026
8-K Current report
Material agreement, New debt
Aug 21, 2026 Aug 21, 2026
8-K Current report
Material agreement, Unregistered share sale
Aug 20, 2026 Aug 19, 2026
8-K Current report
Listing notice
Aug 17, 2026 Aug 14, 2026
8-K Current report
Shareholder vote results
Aug 11, 2026 Aug 11, 2026
8-K Current report
Material agreement
Jul 29, 2026 Jul 28, 2026
8-K Current report
Listing notice
Jul 27, 2026 Jul 24, 2026
8-K Current report
Bylaw or fiscal year change
Jun 17, 2026 Jun 16, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
May 19, 2026 May 14, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Apr 22, 2026 Apr 17, 2026
8-K Current report
Regulation FD disclosure
Feb 25, 2026 Feb 24, 2026
8-K Current report
Listing notice, Other events
Jan 23, 2026 Jan 21, 2026
8-K Current report
Other events
Dec 5, 2025 Dec 5, 2025
8-K Current report
Material agreement
Oct 15, 2025 Oct 15, 2025
8-K Current report
Other events
Sep 22, 2025 Sep 22, 2025
8-K Current report
Officer or director change
Aug 4, 2025 Aug 1, 2025
8-K Current report
Officer or director change
Jul 21, 2025 Jul 17, 2025
8-K Current report
Shareholder vote results
Jul 17, 2025 Jul 16, 2025
8-K Current report
Other events
Jun 9, 2025 Jun 6, 2025
8-K Current report
Material agreement, Other events
May 6, 2025 May 4, 2025
8-K Current report
Material agreement
May 5, 2025 May 5, 2025
8-K Current report
Auditor change
Apr 17, 2025 Apr 16, 2025
8-K Current report
Other events
Feb 6, 2025 Feb 3, 2025
8-K Current report
Other events
Nov 1, 2024 Nov 1, 2024
8-K Current report
Listing notice
Sep 25, 2024 Sep 23, 2024
8-K Current report
Officer or director change
Sep 19, 2024 Sep 16, 2024
8-K Current report
Shareholder vote results
Sep 3, 2024 Aug 26, 2024
8-K Current report
Officer or director change
Jul 30, 2024 Jul 29, 2024
8-K Current report
Other events
Jul 16, 2024 Jul 16, 2024
8-K Current report
Material agreement, Other events
Jul 3, 2024 Jul 2, 2024
8-K Current report
Material agreement, Other events
Jun 28, 2024 Jun 27, 2024
8-K Current report
Other events
Jun 18, 2024 Jun 13, 2024
8-K Current report
Listing notice
May 21, 2024 May 16, 2024
8-K Current report
Other events
Apr 26, 2024 Apr 25, 2024
8-K Current report
Other events
Apr 11, 2024 Apr 10, 2024
8-K Current report
Shareholder vote results
Mar 20, 2024 Mar 7, 2024
8-K Current report
Listing notice
Nov 13, 2023 Nov 7, 2023
8-K Current report
Officer or director change
Sep 28, 2023 Sep 21, 2023
8-K Current report
Material agreement
Jun 2, 2023 May 31, 2023
8-K Current report
Listing notice
May 16, 2023 May 10, 2023
8-K Current report
Auditor change
Oct 3, 2022 Sep 30, 2022
8-K/A Amended current report
Material agreement, Other events
Sep 20, 2022 Sep 20, 2022
8-K Current report
Material agreement, Other events
Sep 20, 2022 Sep 20, 2022
8-K Current report
Material agreement, Other events
Sep 16, 2022 Sep 15, 2022

Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NXL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
, Emerging growth company
SEC CIK
1527352

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.